Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56576 - 56600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	RAB31	11031	upregulated	panobinostat results in increased expression of RAB31 mRNA	18p11.22	A21037
Panobinostat	Approved Investigational	RAB33A	9363	downregulated	panobinostat results in decreased expression of RAB33A mRNA	Xq26.1	A21037
Panobinostat	Approved Investigational	RAB3C	115827	upregulated	panobinostat results in increased expression of RAB3C mRNA	5q11.2	A21037
Panobinostat	Approved Investigational	RAB3IP	117177	downregulated	panobinostat results in decreased expression of RAB3IP mRNA	12q15	A21037
Panobinostat	Approved Investigational	RAB7B	338382	upregulated	panobinostat results in increased expression of RAB7B mRNA	1q32.1	A21037
Panobinostat	Approved Investigational	RABGAP1L	9910	upregulated	panobinostat results in increased expression of RABGAP1L mRNA	1q25.1	A21037
Panobinostat	Approved Investigational	RAC2	5880	upregulated	panobinostat results in increased expression of RAC2 mRNA	22q13.1	A21037
Panobinostat	Approved Investigational	RARB	5915	upregulated	panobinostat results in increased expression of RARB mRNA	3p24.2	A21037
Panobinostat	Approved Investigational	RARRES2	5919	upregulated	panobinostat results in increased expression of RARRES2 mRNA	7q36.1	A21037
Panobinostat	Approved Investigational	RASA2	5922	downregulated	panobinostat results in decreased expression of RASA2 mRNA	3q23	A21037
Panobinostat	Approved Investigational	RASEF	158158	upregulated	panobinostat results in increased expression of RASEF mRNA	9q21.32	A21037
Panobinostat	Approved Investigational	RASSF10	644943	downregulated	panobinostat results in decreased expression of RASSF10 mRNA	11p15.2	A21037
Panobinostat	Approved Investigational	RASSF3	283349	upregulated	panobinostat results in increased expression of RASSF3 mRNA	12q14.2	A21037
Panobinostat	Approved Investigational	RAX	30062	downregulated	panobinostat results in decreased expression of RAX mRNA	18q21.32	A21037
Panobinostat	Approved Investigational	RBFOX1	54715	upregulated	panobinostat results in increased expression of RBFOX1 mRNA	16p13.3	A21037
Panobinostat	Approved Investigational	RBFOX3	146713	downregulated	panobinostat results in decreased expression of RBFOX3 mRNA	17q25.3	A21037
Panobinostat	Approved Investigational	RBM24	221662	downregulated	panobinostat results in decreased expression of RBM24 mRNA	6p22.3	A21037
Panobinostat	Approved Investigational	RBM43	375287	upregulated	panobinostat results in increased expression of RBM43 mRNA	2q23.3	A21037
Panobinostat	Approved Investigational	RBP1	5947	upregulated	panobinostat results in increased expression of RBP1 mRNA	3q23	A21037
Panobinostat	Approved Investigational	RBPMS2	348093	upregulated	panobinostat results in increased expression of RBPMS2 mRNA	15q22.31	A21037
Panobinostat	Approved Investigational	RCAN1	1827	upregulated	panobinostat results in increased expression of RCAN1 mRNA	21q22.12	A21037
Panobinostat	Approved Investigational	RELN	5649	upregulated	panobinostat results in increased expression of RELN mRNA	7q22.1	A21037
Panobinostat	Approved Investigational	REST	5978	upregulated	panobinostat results in increased expression of REST mRNA	4q12	A21037
Panobinostat	Approved Investigational	RFTN2	130132	upregulated	panobinostat results in increased expression of RFTN2 mRNA	2q33.1	A21037
Panobinostat	Approved Investigational	RFX4	5992	upregulated	panobinostat results in increased expression of RFX4 mRNA	12q23.3	A21037

Displaying entries 56576 - 56600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability